Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

White House/FDA tobacco regulation proposal could cloud FDA reform debate.

This article was originally published in The Tan Sheet

Executive Summary

FDA NICOTINE REGULATION FLARE-UP COULD DISTRACT CONGRESS FROM REFORM efforts. The timing of President Clinton's go-ahead for introduction of an FDA proposal to regulate cigarettes as "restricted devices" may deflect legislators' attention away from FDA reform just as the issue is poised to gain momentum through reform proposals under development by the Senate Labor & Human Resources Committee and the House Commerce Committee.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS084185

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel